Global Biosimilars Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	120 Pages	TechNavio	November, 2022	INF17540142

Best Price Guarantee
Price	from $2,500
Length	120 Pages
Publisher	TechNavio
Published Date	November, 2022
SKU	INF17540142

Global Biosimilars Market 2023-2027

Technavio has been monitoring the biosimilars market and it is poised to grow by $42227.12 mn during 2023-2027, accelerating at a CAGR of 23% during the forecast period. Our report on the biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by price advantage of biosimilars over biologics, the patent expiry of major biologics, and government initiatives to increase the use of biosimilar medicines.

Technavio's biosimilars market is segmented as below:

By Product Type

Monoclonal antibodies
Insulin
Human growth hormone
Others

By Application

Oncology and hematology
Endocrinology
Immunology
Nephrology

By Geographical Landscape

Europe
North America
Asia
Rest of World (ROW)

This study identifies the patients' and physicians' willingness to switch to biosimilars as one of the prime reasons driving the biosimilars market growth during the next few years. Also, therapeutic interchangeability regulations for biosimilars across countries and biosimilar's patent dance will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biosimilars market covers the following areas:

Biosimilars market sizing
Biosimilars market forecast
Biosimilars market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimilars market vendors that include AbbVie Inc., Amgen Inc., Biocon Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Celltrion Healthcare Co. Ltd., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gedeon Richter Plc, Halozyme Therapeutics Inc, Intas Pharmaceuticals Ltd., Mabion S.A., Novartis AG, Pfizer Inc., Samsung Biologics Co. Ltd., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the biosimilars market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Chart on Market Overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Chart on Global Market Characteristics
  - Table Executive Summary - Chart on Market by Geography
  - Table Executive Summary - Chart on Market Segmentation by Product Type
  - Table Executive Summary - Chart on Market Segmentation by Application
  - Table Executive Summary - Chart on Incremental Growth
  - Table Executive Summary - Data Table on Incremental Growth
  - Table Executive Summary - Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global biosimilars market 2017 - 2021
  - Table Historic Market Size - Data table on global biosimilars market 2017 - 2021 ($ million)
- Product type Segment Analysis 2017 - 2021
  - Table Historic Market Size - Product type Segment 2017 - 2021 ($ million)
- Application Segment Analysis 2017 - 2021
  - Table Historic Market Size - Application Segment 2017 - 2021 ($ million)
- Geography Segment Analysis 2017 - 2021
  - Table Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- Country Segment Analysis 2017 - 2021
  - Table Historic Market Size - Country Segment 2017 - 2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants - Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes - Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry - Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Product Type
- Market segments
  - Table Chart on Product Type - Market share 2022-2027 (%)
  - Table Data Table on Product Type - Market share 2022-2027 (%)
- Comparison by Product Type
  - Table Chart on Comparison by Product Type
  - Table Data Table on Comparison by Product Type
- Monoclonal antibodies - Market size and forecast 2022- 2027
  - Table Chart on Monoclonal antibodies - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Monoclonal antibodies - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
- Insulin - Market size and forecast 2022-2027
  - Table Chart on Insulin - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Insulin - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Insulin - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Insulin - Year-over-year growth 2022-2027 (%)
- Human growth hormone - Market size and forecast 2022- 2027
  - Table Chart on Human growth hormone - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Human growth hormone - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Human growth hormone - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Human growth hormone - Year-over-year growth 2022-2027 (%)
- Others - Market size and forecast 2022-2027
  - Table Chart on Others - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Others - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Others - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Others - Year-over-year growth 2022-2027 (%)
- Market opportunity by Product Type
  - Table Market opportunity by Product Type ($ million)
Market Segmentation by Application
- Market segments
  - Table Chart on Application - Market share 2022-2027 (%)
  - Table Data Table on Application - Market share 2022-2027 (%)
- Comparison by Application
  - Table Chart on Comparison by Application
  - Table Data Table on Comparison by Application
- Oncology and hematology - Market size and forecast 2022-2027
  - Table Chart on Oncology and hematology - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Oncology and hematology - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Oncology and hematology - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Oncology and hematology - Year-over-year growth 2022-2027 (%)
- Endocrinology - Market size and forecast 2022-2027
  - Table Chart on Endocrinology - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Endocrinology - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Endocrinology - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Endocrinology - Year-over-year growth 2022-2027 (%)
- Immunology - Market size and forecast 2022-2027
  - Table Chart on Immunology - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Immunology - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Immunology - Year-over-year growth 2022-2027 (%)
- Nephrology - Market size and forecast 2022-2027
  - Table Chart on Nephrology - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Nephrology - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Nephrology - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Nephrology - Year-over-year growth 2022-2027 (%)
- Market opportunity by Application
  - Table Market opportunity by Application ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ million)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022- 2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ million)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- UK - Market size and forecast 2022-2027
  - Table Chart on UK - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on UK - Market size and forecast 2022-2027 ($ million)
  - Table Chart on UK - Year-over-year growth 2022-2027 (%)
  - Table Data Table on UK - Year-over-year growth 2022-2027 (%)
- China - Market size and forecast 2022-2027
  - Table Chart on China - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on China - Market size and forecast 2022-2027 ($ million)
  - Table Chart on China - Year-over-year growth 2022-2027 (%)
  - Table Data Table on China - Year-over-year growth 2022-2027 (%)
- Republic of Korea - Market size and forecast 2022-2027
  - Table Chart on Republic of Korea - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Republic of Korea - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Republic of Korea - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Republic of Korea - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Price advantage of biosimilars over biologics
  - Patent expiry of major biologics
  - Government initiatives to increase the use of biosimilar medicines
- Market challenges
  - Market access barriers for biosimilars
  - Supply chain challenges of biosimilars
  - Obstacles to reimbursement of biosimilars
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Patients and physician's willingness to switch to biosimilars
  - Therapeutic interchangeability regulations for biosimilars across countries
  - Biosimilar's patent dance
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key offerings
- Amgen Inc.
  - Table Amgen Inc. - Overview
  - Table Amgen Inc. - Product / Service
  - Table Amgen Inc. - Key offerings
- Biocon Ltd.
  - Table Biocon Ltd. - Overview
  - Table Biocon Ltd. - Business segments
  - Table Biocon Ltd. - Key offerings
  - Table Biocon Ltd. - Segment focus
- Biogen Inc.
  - Table Biogen Inc. - Overview
  - Table Biogen Inc. - Product / Service
  - Table Biogen Inc. - Key offerings
- Boehringer Ingelheim International GmbH
  - Table Boehringer Ingelheim International GmbH - Overview
  - Table Boehringer Ingelheim International GmbH - Business segments
  - Table Boehringer Ingelheim International GmbH - Key news
  - Table Boehringer Ingelheim International GmbH - Key offerings
  - Table Boehringer Ingelheim International GmbH - Segment focus
- Celltrion Healthcare Co. Ltd.
  - Table Celltrion Healthcare Co. Ltd. - Overview
  - Table Celltrion Healthcare Co. Ltd. - Product / Service
  - Table Celltrion Healthcare Co. Ltd. - Key offerings
- Dr Reddys Laboratories Ltd.
  - Table Dr Reddys Laboratories Ltd. - Overview
  - Table Dr Reddys Laboratories Ltd. - Business segments
  - Table Dr Reddys Laboratories Ltd. - Key offerings
  - Table Dr Reddys Laboratories Ltd. - Segment focus
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Fresenius SE and Co. KGaA
  - Table Fresenius SE and Co. KGaA - Overview
  - Table Fresenius SE and Co. KGaA - Business segments
  - Table Fresenius SE and Co. KGaA - Key news
  - Table Fresenius SE and Co. KGaA - Key offerings
  - Table Fresenius SE and Co. KGaA - Segment focus
- Gedeon Richter Plc
  - Table Gedeon Richter Plc - Overview
  - Table Gedeon Richter Plc - Business segments
  - Table Gedeon Richter Plc - Key news
  - Table Gedeon Richter Plc - Key offerings
  - Table Gedeon Richter Plc - Segment focus
- Halozyme Therapeutics Inc
  - Table Halozyme Therapeutics Inc - Overview
  - Table Halozyme Therapeutics Inc - Product / Service
  - Table Halozyme Therapeutics Inc - Key offerings
- Intas Pharmaceuticals Ltd.
  - Table Intas Pharmaceuticals Ltd. - Overview
  - Table Intas Pharmaceuticals Ltd. - Product / Service
  - Table Intas Pharmaceuticals Ltd. - Key offerings
- Mabion S.A.
  - Table Mabion S.A. - Overview
  - Table Mabion S.A. - Product / Service
  - Table Mabion S.A. - Key offerings
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Viatris Inc.
  - Table Viatris Inc. - Overview
  - Table Viatris Inc. - Business segments
  - Table Viatris Inc. - Key offerings
  - Table Viatris Inc. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations